Buy Brainstorm Cell Therapeutics Stock | BCLI Stock Price & Latest News | Public.com
BCLI

Brainstorm Cell Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Brainstorm Cell Therapeutics (BCLI) stock trends here

    About BCLI

    Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops and commercializes adult stem cell therapeutic products. It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective tr...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.12
    -0.25
    -0.37
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.26

    Actual EPS
    Q2 2021

    Stats

    Market Cap$111,8M
    Volume83,15k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$17.95
    1 Year Low$3.03
    Open$3.07
    High$3.15
    Low$3.06

    Buy any stock with any amount of money.

    Download the App
    Download the app